About Glpverdict
The independent GLP-1 telehealth review portal
Glpverdict is an editorial review portal that ranks GLP-1 telehealth providers and summarises GLP-1 medications for US consumers. We are affiliate-funded, editorially independent, and medically reviewed. We do not prescribe medication, do not collect payment, and never accept pharmaceutical-company sponsorship of editorial content.
- Ranked provider listings β every GLP-1 telehealth provider scored on price, medication menu, insurance acceptance, and patient experience. Methodology is fully documented at /how-we-rank.
- Medication profiles β Wegovy, Ozempic, Zepbound, Mounjaro, Saxenda, Rybelsus, and emerging agents. Each profile cites the FDA prescribing information; clinical claims trace back to peer-reviewed sources.
- Tools + calculators β savings calculator, dose-escalation calendar, insurance coverage lookup, and a real-cohort outcomes tracker for opt-in users.
- Editorial articles β clinical news, policy changes, side-effect deep-dives. Every YMYL article is reviewed by a named clinician listed on /authors.
3 named clinical contributors review our content β physicians, dietitians, and nurse practitioners with documented GLP-1 / obesity-medicine expertise. Each contributor has a public byline page at /authors with credentials, specialties, and review history.
Glpverdict earns affiliate commission when a reader clicks a tracked /go/{slug} link and completes signup with a telehealth provider. Commission size does NOT change ranking order β see /editorial-standards for our independence guarantee, and /refunds for how refunds work (they don't go through us). We accept no pharmaceutical-company payments of any form β no sponsored articles, no co-marketing, no influencer fees.
- FTC 16 CFR Β§255 β every affiliate CTA pairs with a clear and conspicuous material-connection disclosure.
- FDA + YMYL β clinical claims cite FDA prescribing information or peer-reviewed primary sources (NEJM, JAMA, Lancet).
- GDPR + CCPA β user data is processed under a documented lawful basis; data-subject requests are handled within statutory windows via /privacy.
- WCAG 2.1 AA β accessibility statement at /accessibility.
- COPPA β content is directed at adults 18+; minors should not submit personal data.
- Trading as
- Glpverdict
- Operator
- Glpverdict Media LLC (US)
- Founded
- 2024
- Jurisdiction
- Delaware, United States
- Compliance contact
- [email protected]
Affiliate-network partners requiring W-9, EIN, or DUNS verification: request via [email protected]. Operator registration details visible to network compliance officers under NDA.
Founded 2024. Last verified June 22, 2026. Contact: /contact.